Table 2.
The frequency of extramedullary initial presentations of ALL in studies
| Locations | N (Studies) | Frequency of cases | M:F Ratio | Mean of ages (y) ± SD |
|---|---|---|---|---|
| Musculoskeletal symptoms | 17 | 19.5% | 3:1 | 5.6±3.6 (1-14 Y) |
| Renal symptoms | 17 | 19.5% | 0.7:1 | 5.31±3 (0.5-12.3 Y) |
| Hepatic symptom | 12 | 13.8% | 2:1 | 9.2±4.9 (4-18 Y) |
| Ophthalmic symptoms | 10 | 11.5% | 1.5:1 | 6.8±5.6 (1.5-18 Y) |
| Neurological symptom | 8 | 9% | 1.6:1 | 10.6±3.5 (7-18 Y) |
| Eosinophilia | 5 | 5.8% | 1.5:1 | 6.3±3 (3-11 Y) |
| Skin involvement | 5 | 5.8% | 1.5:1 | 5.7±4.7 (0.5-11 Y) |
| Oral symptom | 5 | 5.8% | 5:1 | 9±5.2 (5-18 Y) |
| Abdominal symptom | 3 | 3.5% | 3:1 | 8.6±4.7 (5-14 Y) |
| Cardiac Symptom | 2 | 2.3% | 1:1 | 6.5±0.7 (6-7 Y) |
| Miscellaneous | 3 | 3.5% | 4:1 | 12.7±7.5 (2-18 Y) |
| Lactic Acidosis | ||||
| Chylothorax | ||||
| Thyroid Nodule | ||||
| Totally | 87 | 100% | 1.9:1 | 7.3±4.6 (0.5-18 Y) |
SD: Standard Deviation, N: Number of Patients, Y: Years Old.